Amneal Pharmaceuticals Inc. (AMRX) at a glance

Amneal Pharmaceuticals Inc. (AMRX) is a mid-cap Healthcare company. It trades at $17.01, with a P/E of 43.8, a 4% profit margin and revenue growth of 3.9%. It does not pay a dividend. Vestovix scores it 52/100 overall. Its strongest dimension is Growth (75/100) and its weakest is Safety (38/100). It carries above-market volatility, so expect larger swings.

Price

$17.01

Market cap

$5.17B

P/E ratio

43.8

Dividend yield

None

Beta

1.32

52-week range

$9.27 to $19.26